Riten Kumar, MD, MSc

Department of Pediatrics
Dana Farber/Boston Children’s Cancer and Blood Disorders Center; Harvard Medical School
Boston, Massachusetts, United States

Dr. Kumar is the Medical Director of the Thrombosis, Anticoagulation and Vascular Patency Program at Boston Children’s Hospital and an Associate Professor of Pediatrics at the Harvard Medical School. After completing medical school at the University of Calcutta, he did his postgraduate training at SUNY Downstate, New York and the Mayo Clinic, Minnesota. In 2013, Dr Kumar completed a second fellowship in Pediatric Thrombosis/Hemostasis at the Hospital for Sick Children in Toronto, Canada.

Presentation(s):

• OC 06.4 - Safety and Efficacy of Direct Oral Anticoagulants in Pediatric Oncology Patients: Real-World Experience from two Quaternary Care Pediatric Centers

  Saturday, June 22, 2024
  13:45 – 14:00 ICT

• PB0590 - Venous Thrombo-embolism in Transgender and Gender Non-Binary Adolescents: An Administrative Database Study

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• OC 65.3 - Prognostic factors for complete and partial veno-occlusion following an initial six weeks of anticoagulant therapy for first-episode provoked venous thromboembolism (VTE) in patients < 21 years

  Tuesday, June 25, 2024
  15:15 – 15:30 ICT

• OC 65.5 - Clinical and Laboratory-Based Risk Factors for the Development of Post-Thrombotic Syndrome (PTS) in Children with Provoked Deep Venous Thrombosis (DVT): Findings from the Kids-DOTT Trial and Biobank

  Tuesday, June 25, 2024
  15:45 – 16:00 ICT

• OC 72.6 - Diagnostic tools to improve the care of pediatric hemostasis disorders

  Wednesday, June 26, 2024
  10:15 – 11:30 ICT